# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 155: Amendment of regulation 195 (obligation on licensing authority to assess PSURs)


(1) Regulation 195 is amended as follows.
(2) In the heading, omit “where EU single assessment procedure does not apply”.
(3) For paragraph (1) substitute—
“(1) This regulation applies where PSURs relating to a medicinal product have been submitted to the licensing authority under regulations 191 to 192.”.
(4) After paragraph (3) insert—
“(3A) If the licensing authority considers under paragraph (3)(b) that an authorisation or registration needs to be varied, it may require the holder to submit to the licensing authority, within a time period that the licensing authority specifies, an application for a variation, including—
(a) an updated summary of the product characteristics; and
(b) an updated package leaflet.”.
(5) In paragraph (4), omit the definitions of “EU reference date” and “EU single assessment procedure”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179185/regulation/155 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-155
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.